Muscle of obese 'programmed' to amass fat, genetic study finds

October 11, 2005

The skeletal muscle of severely obese people is "programmed" to amass fat, a study in the October 2005 issue of Cell Metabolism reveals. The findings suggest that muscle bears a metabolic memory of obesity, which may help to explain why sustained weight loss can be difficult despite cutting calories, according to the researchers. Exercise might more successfully override the aberrant metabolic program in muscle, they suggest, thereby improving the long-term prognosis of those prone to obesity.

A diverse team of researchers found that the fat-building enzyme stearoyl-CoA desaturase-1 (SCD-1) is three times more abundant in muscle taken from obese people than in muscle from those who are lean. The newly discovered elevation in enzyme activity elucidates an important link between obesity, diabetes, and abnormal fat buildup in muscle, said study author Deborah Muoio of the Sarah W. Stedman Nutrition and Metabolism Center at Duke University Medical Center.

"Obesity and type 2 diabetes are strongly associated with abnormal lipid metabolism and the accumulation of fat droplets in muscle, but the underlying causes of these perturbations have been unknown," Muoio said. "We've now shown that SCD1 is at least a very important contributor to changes in lipid handling within muscle and the progression of obesity."

The researchers examined muscle removed from lean and obese patients during surgery. An earlier study had found that the obese individuals, while not diabetic, did show severe insulin resistance. The muscle of those individuals was laced with fat droplets, they found, and also showed a 43% decline in the ability to burn fat.

Results of a comprehensive profile of gene activity showed a link between obesity and a 3-fold increase in muscle SCD1 levels. That increase in enzyme expression and activity also corresponded with diminished fat burning and changes in the fat composition of muscle. In contrast, many other genes with known roles in fat production did not differ between obese and lean people, they reported.

The differences between muscles of lean and obese donors persisted in primary myocytes--cells poised to differentiate into muscle tissue. Muscle cells from lean individuals, when forced to over-produce SCD1, also took on characteristics that mimicked those seen in the cells of obese people.

The findings suggest that the muscular abnormalities seen in obese individuals stemmed from an inherited genetic predisposition or from imprinted defects in metabolic genes, Muoio said. Imprinting, or epigenetics, refers to permanent or semipermanent modification in gene activity states not conferred by changes in the underlying DNA sequence.

"Compelling evidence indicates that deviant nutrition during critical developmental periods can impose imprinted metabolic adaptations that persist into adulthood," the researchers wrote. "Such observations suggest that transient environmental stress can trigger permanent alterations in metabolic control. Thus, our findings could reflect an epigenetic phenomenon in which obesity-induced modifications in gene activity provoke irreversible perturbations in SCD1 gene regulation."

"While these findings may be somewhat discouraging news for those wishing to reverse obesity through dietary interventions, they also highlight the importance of exercise," Muoio said.

Exercise is known to produce robust changes in muscle metabolism, she explained. Further study will examine whether increased physical activity can reverse the elevation in SCD1 or circumvent its effects through independent mechanisms, she added.
-end-
The researchers include Matthew W. Hulver and Michael J. Carper of the Louisiana State University System, Baton Rouge, Louisiana; Jason R. Berggren and G. Joseph A. Houmard of East Carolina University, Greenville, North Carolina; Makoto Miyazaki and James M. Ntambi of the University of Wisconsin, Madison; Eric P. Hoffman of the Children's National Medical Center, Washington, DC; John P. Thyfault and Lynis Dohm of East Carolina University, Greenville, North Carolina; Robert Stevens and Deborah M. Muoio6 of the Duke University Medical Center, Durham, North Carolina. This work was supported by the National Institute of Health Diabetes and Digestive and Kidney Diseases; the Pennington Biomedical Research Foundation and the American Diabetes Association.

Hulver et al.: "Elevated Stearoyl-CoA Desaturase-1 Expression in Skeletal Muscle Contributes to Abnormal Fatty Acid Partitioning in Obese Humans," Publishing in Cell Metabolism Volume 2, October 2005, pages 251-261. DOI 10.1016/j.cmet.2005.09.002 www.cellmetabolism.org

Cell Press

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.